PTC
COLL icon

Petrus Trust Company’s Collegium Pharmaceutical COLL Stock Holding History

Petrus Trust Company’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-6,154
Closed -$239K – 614
2024
Q1 		$239K Sell
6,154
-9,316
-60% -$326K 0.02% 522
2023
Q4 		$476K Hold
15,470
– – 0.05% 238
2023
Q3 		$346K Hold
15,470
– – 0.04% 344
2023
Q2 		$332K Sell
15,470
-4,244
-22% -$96.4K 0.04% 317
2023
Q1 		$473K Buy
19,714
+6,560
+50% +$174K 0.06% 115
2022
Q4 		$305K Sell
13,154
-3,876
-23% -$78.2K 0.04% 258
2022
Q3 		$273K Buy
+17,030
New +$300K 0.04% 96

Other funds holding COLL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Petrus Trust Company's COLL Position: Q2 2024 in Review

Petrus Trust Company sold out of Collegium Pharmaceutical (COLL) in Q2 2024, closing a stake of 6,154 shares — an estimated $239K sold.

Petrus Trust Company first reported a position in COLL in Q3 2022 and held it in 7 quarters. The position peaked at $476K in Q4 2023. 229 funds tracked by Wall St. Rank hold COLL as of Q2 2024.

  • Petrus Trust Company reported no remaining Collegium Pharmaceutical position as of Q2 2024 after selling out during the quarter.
  • Petrus Trust Company sold 6,154 Collegium Pharmaceutical shares in Q2 2024, an estimated $239K.
  • Petrus Trust Company first reported a position in Collegium Pharmaceutical in Q3 2022 and held it in 7 quarters.
  • Petrus Trust Company's Collegium Pharmaceutical position peaked at $476K in Q4 2023.
  • 229 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2024.

Based on Petrus Trust Company's 13F filing for Q2 2024, filed 14 Aug 2024.